Teva Pharmaceutical Industries Market Cap 2006-2018 | TEVA

Teva Pharmaceutical Industries market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Teva Pharmaceutical Industries market cap as of April 23, 2019 is $15.16B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $15.162B $18.854B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $47.288B 8.51
Mylan (MYL) United Kingdom $13.724B 5.81
Bausch Health Cos (BHC) Canada $8.210B 5.84
Dr Reddy's Laboratories (RDY) India $6.790B 27.08
Supernus Pharmaceuticals (SUPN) United States $1.951B 18.10
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.534B 2.49
Amphastar Pharmaceuticals (AMPH) United States $0.979B 90.43
Homology Medicines (FIXX) United States $0.873B 0.00
CymaBay Therapeutics (CBAY) United States $0.742B 0.00
Voyager Therapeutics (VYGR) United States $0.677B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.429B 0.00
Assembly Biosciences (ASMB) United States $0.389B 0.00
Akorn (AKRX) United States $0.374B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.209B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.175B 0.00
Sol-Gel Technologies (SLGL) Israel $0.133B 0.00
Acasti Pharma (ACST) Canada $0.069B 0.00
Agile Therapeutics (AGRX) United States $0.063B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Teligent (TLGT) United States $0.053B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.012B 0.00